{"id":8499,"date":"2010-09-02T08:53:00","date_gmt":"2010-09-02T08:53:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=8499"},"modified":"2022-10-26T08:58:30","modified_gmt":"2022-10-26T08:58:30","slug":"13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/","title":{"rendered":"13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis – the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan"},"content":{"rendered":"
\n

M.I wamoto K.Shigetoh H. Maruyama T. Kondo<\/a> Transfusion and Apheresis Science<\/a> Volume 43, Supplement<\/a>,\u00a0September 2010, Pages S6-S7 doi.: .10.1016\/S1473-0502(10)70013-6<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1473050210700136<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

M.I wamoto K.Shigetoh H. Maruyama T. Kondo Transfusion and Apheresis Science Volume 43, Supplement,\u00a0September 2010, Pages S6-S7 doi.: .10.1016\/S1473-0502(10)70013-6 https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1473050210700136<\/p>\n","protected":false},"template":"","scientific_tags":[424,148,53,156,55,135,306],"class_list":["post-8499","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-gma","scientific_tags-long-term-efficacy","scientific_tags-refractory-patients","scientific_tags-safety","scientific_tags-steroid-dependent","scientific_tags-steroid-refractory","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":""},"yoast_head":"\n13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan - Adacyte\" \/>\n<meta property=\"og:description\" content=\"M.I wamoto K.Shigetoh H. Maruyama T. Kondo Transfusion and Apheresis Science Volume 43, Supplement,\u00a0September 2010, Pages S6-S7 doi.: .10.1016\/S1473-0502(10)70013-6 https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1473050210700136\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-26T08:58:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/\",\"name\":\"13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2010-09-02T08:53:00+00:00\",\"dateModified\":\"2022-10-26T08:58:30+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/","og_locale":"es_ES","og_type":"article","og_title":"13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan - Adacyte","og_description":"M.I wamoto K.Shigetoh H. Maruyama T. Kondo Transfusion and Apheresis Science Volume 43, Supplement,\u00a0September 2010, Pages S6-S7 doi.: .10.1016\/S1473-0502(10)70013-6 https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1473050210700136","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/","og_site_name":"Adacyte","article_modified_time":"2022-10-26T08:58:30+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/","name":"13 Apheresis therapy showed its high safety and adequate efficacy for the treatment of patients with ulcerative colitis - the postmarketing surveillance of more than 600 ulcerative colitis patients in Japan - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2010-09-02T08:53:00+00:00","dateModified":"2022-10-26T08:58:30+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/13-apheresis-therapy-showed-its-high-safety-and-adequate-efficacy-for-the-treatment-of-patients-with-ulcerative-colitis-the-postmarketing-surveillance-of-more-than-600-ulcerative-colitis-patients-in\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/8499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=8499"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=8499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}